TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC) ...

Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.

Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...

Breast cancer is the second leading malignant disease in females worldwide. Over decades of research, breast cancer classification by molecular subtypes has ...

Most people with breast cancer get more than one type of treatment, depending on the kind of breast cancer they have and how far it has spread. Certain types of breast cancer, like triple-negative ...

Biopsy results soon confirmed her biggest fear - she had stage two triple-negative breast cancer (TNBC). Shocked and devastated by the life-changing news, Katie contacted her sister, Lyndsay ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy ...